U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
105241105241Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced MalignanciesActive, not recruitingNo Results AvailableNeoplasmsDrug: Roniciclib (BAY1000394)https://ClinicalTrials.gov/show/NCT01188252
105242105242A Structured Protocol to Evaluate Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette) Efficacy and Safety of a Popular Electronic Nicotine Delivery Device (E-Cigarette)CompletedNo Results AvailableHealthy Smokers|Smoking Cessationhttps://ClinicalTrials.gov/show/NCT01188239
105243105243Wear Characteristics of Denture TeethEnrolling by invitationNo Results AvailableDenturesDevice: Denture teethhttps://ClinicalTrials.gov/show/NCT01188226
105244105244Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled StudyCompletedNo Results AvailableKnee OsteoarthritisDietary Supplement: Methylsulfonylmethane (MSM)https://ClinicalTrials.gov/show/NCT01188213
105245105245Four-Hour Evaluation of a Medical Food in Subjects With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Other: Experimental nutritional formula #M979|Other: Standard foodhttps://ClinicalTrials.gov/show/NCT01188200
105246105246Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate CancerCompletedNo Results AvailableProstate CancerDrug: Custirsen Sodium, Docetaxel, Prednisone|Drug: Docetaxel, Prednisonehttps://ClinicalTrials.gov/show/NCT01188187
105247105247Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment FailureCompletedNo Results AvailableAMLDrug: Clofarabinehttps://ClinicalTrials.gov/show/NCT01188174
105248105248Postural Effects of Being Rotated in a Whole Body GyroscopeCompletedNo Results AvailableFalls|Balance|Movement DisordersDevice: Rotating Chairhttps://ClinicalTrials.gov/show/NCT01188161
105249105249Series Studies of Bipolar Disorder-Valproate add-on MemantineCompletedNo Results AvailableBipolar DisordersDrug: Memantine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01188148
105250105250Antidepressant Adherence Via AD_IVRCompletedNo Results AvailableMajor Depressive DisorderBehavioral: Interactive voice messaging or Interactive voice messaging + psycho ed materialshttps://ClinicalTrials.gov/show/NCT01188135
105251105251Optimal Endotracheal Cuff Pressure During Hospitalization in Intensive Care Units Using AnapnoGuard 100 SystemCompletedNo Results AvailableVentilator Associated PneumoniaDevice: AnapnoGuard 100https://ClinicalTrials.gov/show/NCT01188122
105252105252Gemcitabine/Cisplatin for Resected Pancreas Cancer: Establishing the Role of ERCC1 in Treatment DecisionTerminatedNo Results AvailablePancreatic Neoplasms|Pancreatic CancerDrug: Gemcitabine|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT01188109
105253105253A Trial of Poly-ICLC in the Management of Recurrent Pediatric Low Grade GliomasRecruitingNo Results AvailableBrain TumorsDrug: Poly ICLChttps://ClinicalTrials.gov/show/NCT01188096
105254105254Effects of Dietary Fructose Reduction in Children With Hepatic SteatosisCompletedNo Results AvailableNon-alcoholic Fatty-liver DiseaseDietary Supplement: Fructose Drink|Dietary Supplement: Glucose Drinkhttps://ClinicalTrials.gov/show/NCT01188083
105255105255Caregiver Stress: Interventions to Promote Health and WellbeingCompletedNo Results AvailableHealth PromotionBehavioral: Usual Care|Behavioral: Psycho-education|Behavioral: Psycho-education plus physical exercisehttps://ClinicalTrials.gov/show/NCT01188070
105256105256A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Non-Fasting ConditionsCompletedNo Results AvailableHealthyDrug: ALPRAZOLAM ORALLY DISINTEGRATING TABLETS, 2.0 MG|Drug: NIRAVAM TM 2 mg orally disintegrating tablets, single dosehttps://ClinicalTrials.gov/show/NCT01188057
105257105257Validating Accelerometers to Study Physical Activity of ToddlersCompletedNo Results AvailableMotor Activityhttps://ClinicalTrials.gov/show/NCT01188044
105258105258A Relative Bioavailability Study of 2 mg Alprazolam OD Tablets Under Fasting ConditionsCompletedNo Results AvailableHealthyDrug: ALPRAZOLAM ORALLY DISINTEGRATING TABLETS, 2.0 MG|Drug: NIRAVAM TM 2 mg orally disintegrating tablets, single dosehttps://ClinicalTrials.gov/show/NCT01188031
105259105259Testing Counseling Styles to Motivate Smokers to QuitCompletedNo Results AvailableSmoking|Tobacco Use|Nicotine DependenceBehavioral: Brief Advice (BA)|Behavioral: Motivational Interviewing (MI)|Behavioral: Health Education (HE)https://ClinicalTrials.gov/show/NCT01188018
105260105260Inflammatory Mediators in Obstructive Sleep Apnoea Syndrome; Mechanisms of Production and the Effect of Long Term Antioxidants AdministrationRecruitingNo Results AvailableObstructive Sleep Apnea SyndromeDevice: n-CPAP|Device: Oxygen supplementation|Drug: Vitamin A, Vitamin C, Vitamin E, Allopurinol, N-Acetylcysteinehttps://ClinicalTrials.gov/show/NCT01188005
105261105261Full-dose Atorvastatin After Acute Coronary Syndrome (ACS) in Non-revascularisable Coronary Artery DiseaseTerminatedNo Results AvailableAcute Coronary Syndrome|Coronary Artery DiseaseDrug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT01187992
105262105262Reducing HIV in AdolescentsCompletedNo Results AvailableHIV InfectionsBehavioral: Cash incentives|Behavioral: Life skills curriculumhttps://ClinicalTrials.gov/show/NCT01187979
105263105263Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: Safinamide|Drug: Safinamide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01187966
105264105264Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney TxCompletedHas ResultsRenal FailureDrug: Prograf (tacrolimus)|Drug: LCP-Tacrohttps://ClinicalTrials.gov/show/NCT01187953
105265105265Evaluating PEGASUS - a Group Intervention for Young People With an Autism Spectrum DisorderNot yet recruitingNo Results AvailableEfficacy of PEGASUSBehavioral: PEGASUShttps://ClinicalTrials.gov/show/NCT01187940
105266105266Drug Use Investigation for Cervarix®CompletedNo Results AvailableInfections, PapillomavirusBiological: Cervarix®https://ClinicalTrials.gov/show/NCT01187927
105267105267Effect of Structural Remodeling on Scar Formation as Assessed by DE-MRI of the Left AtriumCompletedHas ResultsAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT01187914
105268105268A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis PatientsActive, not recruitingNo Results AvailableAdenomatous Polyposis ColiDrug: Erlotinib|Drug: Sulindac|Drug: Placebo A|Drug: Placebo Bhttps://ClinicalTrials.gov/show/NCT01187901
105269105269Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear PalsyTerminatedNo Results AvailableProgressive Supranuclear PalsyDrug: Rasagiline|Drug: Sugar pillhttps://ClinicalTrials.gov/show/NCT01187888
105270105270Resistant Starch and SatietyCompletedNo Results AvailableHealthy AdultsDietary Supplement: Placebo- Fiber free control|Dietary Supplement: Hi-maize resistant starch 9g|Dietary Supplement: Novalose 330 resistant starch 9g|Dietary Supplement: 4.5g Hi-maize resistant starch and 4.5g Novalose 330https://ClinicalTrials.gov/show/NCT01187875

* Görseller ve İçerik tekif hakkına sahip olabilir